Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 10 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cosyntropin | [1] Tetracosactide Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬1. Cosyntropin
| [1] MC2R MC2R 💬1. Cosyntropin
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [2] 113 113, 145 💬
| ||||||||||||
| 2 | Cosyntropin acetate | [2] Acetate Acetate,Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬2. Cosyntropin acetate
| [1] MC2R MC2R 💬2. Cosyntropin acetate
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [1] 113 113 💬2. Cosyntropin acetate
| ||||||||||||
| 3 | Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin | [2] Tetracosactide Tetracosactide (Cosyntropin),Vigabatrin | [2] Cosyntropin
Cosyntropin
,Vigabatrin 💬 3. Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin
| [2] ABAT ABAT,MC2R 💬 | [12] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 [12] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate met ... | [1] 145 145 💬3. Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin
| ||||||||||||
| 4 | Cosyntropin Injectable Suspension, 1 mg/mL | [1] Tetracosactide Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬4. Cosyntropin Injectable Suspension, 1 mg/mL
| [1] MC2R MC2R 💬4. Cosyntropin Injectable Suspension, 1 mg/mL
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [1] 145 145 💬4. Cosyntropin Injectable Suspension, 1 mg/mL
| ||||||||||||
| 5 | Depot tetracosactide (Cosyntropin) | [1] Tetracosactide Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬5. Depot tetracosactide
| [1] MC2R MC2R 💬5. Depot tetracosactide
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [1] 83 83 💬5. Depot tetracosactide
| ||||||||||||
| 6 | TETRACOSACTIDE (Cosyntropin) | [1] Tetracosactide Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬6. TETRACOSACTIDE
| [1] MC2R MC2R 💬6. TETRACOSACTIDE
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [4] 83 83, 113, 145, 222 💬
| ||||||||||||
| 7 | Tetracosactide Acetate (Cosyntropin) | [2] Acetate Acetate,Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬7. Tetracosactide Acetate
| [1] MC2R MC2R 💬7. Tetracosactide Acetate
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [2] 83 83, 145 💬
| ||||||||||||
| 8 | TETRACOSACTIDE ESACETATO (Cosyntropin) | [1] Tetracosactide Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬8. TETRACOSACTIDE ESACETATO
| [1] MC2R MC2R 💬8. TETRACOSACTIDE ESACETATO
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [1] 113 113 💬8. TETRACOSACTIDE ESACETATO
| ||||||||||||
| 9 | TETRACOSACTIDE HEXAACETATE (Cosyntropin) | [1] Tetracosactide Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬9. TETRACOSACTIDE HEXAACETATE
| [1] MC2R MC2R 💬9. TETRACOSACTIDE HEXAACETATE
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [1] 113 113 💬9. TETRACOSACTIDE HEXAACETATE
| ||||||||||||
| 10 | Tetracosactide hexacetaat (Cosyntropin) | [1] Tetracosactide Tetracosactide (Cosyntropin) | [1] Cosyntropin
Cosyntropin
💬10. Tetracosactide hexacetaat
| [1] MC2R MC2R 💬10. Tetracosactide hexacetaat
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [1] 222 222 💬10. Tetracosactide hexacetaat
|